BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16839794)

  • 1. Human bancroftian filariasis: immunological markers of morbidity and infection.
    Satapathy AK; Sartono E; Sahoo PK; Dentener MA; Michael E; Yazdanbakhsh M; Ravindran B
    Microbes Infect; 2006 Aug; 8(9-10):2414-23. PubMed ID: 16839794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble cellular adhesion molecules, selectins, VEGF and endothelin-1 in patients with Wuchereria bancrofti infection and association with clinical status.
    Esterre P; Plichart C; Huin-Blondey MO; Nguyen LN
    Parasite Immunol; 2005; 27(1-2):9-16. PubMed ID: 15813718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease.
    Anuradha R; George PJ; Pavan Kumar N; Fay MP; Kumaraswami V; Nutman TB; Babu S
    PLoS Pathog; 2012; 8(6):e1002749. PubMed ID: 22685406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines following diethylcarbamazine (DEC) treatment of different clinical groups in lymphatic filariasis.
    Haarbrink M; Terhell AJ; Abadi GK; Mitsui Y; Yazdanbakhsh M
    Trans R Soc Trop Med Hyg; 1999; 93(6):665-72. PubMed ID: 10717762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic filariasis: lymphocyte sub-populations in Wuchereria bancrofti infection.
    Dasgupta A; Bala S; Dutta SN
    J Commun Dis; 1986 Dec; 18(4):295-301. PubMed ID: 3309036
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis.
    Turner PF; Rockett KA; Ottesen EA; Francis H; Awadzi K; Clark IA
    J Infect Dis; 1994 May; 169(5):1071-5. PubMed ID: 8169393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-parasitological assessment of bancroftian filariasis in a highly endemic area along the River Sabaki, in Malindi district, Kenya.
    Njenga SM; Wamae CN; Mwandawiro CS; Molyneux DH
    Ann Trop Med Parasitol; 2007 Mar; 101(2):161-72. PubMed ID: 17316502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filarial infection is resisted differentially by subjects having different blood group phenotypes.
    Dixit V; Pati AK; Gupta AK; Bisen PS; Prasad GB
    J Clin Lab Anal; 2009; 23(3):186-91. PubMed ID: 19455632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lymphatic filariasis: genetic polymorphism of endothelin-1 and tumor necrosis factor receptor II correlates with development of chronic disease.
    Panda AK; Sahoo PK; Kerketta AS; Kar SK; Ravindran B; Satapathy AK
    J Infect Dis; 2011 Jul; 204(2):315-22. PubMed ID: 21673044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune competence in bancroftian filariasis.
    Mistry SS; Subrahmanyam D
    J Trop Med Hyg; 1985 Dec; 88(6):383-8. PubMed ID: 3915514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
    Sahoo PK; Satapathy AK; Michael E; Ravindran B
    Am J Trop Med Hyg; 2005 Nov; 73(5):877-80. PubMed ID: 16282297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating fibrosis markers, eosinophil cationic protein and eosinophil protein X in patients with Wuchereria bancrofti infection: association with clinical status.
    Esterre P; Plichart C; Huin-Blondey MO; Nguyen LN; Hartmann D; Guerret S; Reimert CM; Ricard-Blum S
    Parasite; 2006 Jun; 13(2):165-70. PubMed ID: 16800126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filarial-specific IgG4 response correlates with active Wuchereria bancrofti infection.
    Kwan-Lim GE; Forsyth KP; Maizels RM
    J Immunol; 1990 Dec; 145(12):4298-305. PubMed ID: 2258618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential recognition of Brugia malayi antigens by bancroftian filariasis sera.
    Parab PB; Rajasekariah GR; Carvalho PA; Subrahmanyam D
    Indian J Med Res; 1990 Mar; 91():138-43. PubMed ID: 2188906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic filariasis in Papua New Guinea: prospects for elimination.
    Bockarie MJ; Kazura JW
    Med Microbiol Immunol; 2003 Feb; 192(1):9-14. PubMed ID: 12592558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of gp15/400 allergen gene of Wuchereria bancrofti from different regions of India endemic for lymphatic filariasis.
    Hoti SL; Thangadurai R; Patra KP; Das PK
    Infect Genet Evol; 2007 Mar; 7(2):213-8. PubMed ID: 17056300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of bancroftian filariasis by detection of circulating antigens by counterimmunoelectrophoresis.
    el-Ganayni GA; Romia SA; Makhlouf LM; Hegazi MM
    J Egypt Soc Parasitol; 1988 Dec; 18(2):503-7. PubMed ID: 3047273
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of heterologous adult filarial antigens in detecting serum antibodies in Bancroftian filariasis patients by indirect fluorescent antibody test].
    Wang YC; Jin XX; Feng ZM; Yang RQ
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1986; 4(1):12-3. PubMed ID: 3542280
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications.
    Aravindhan V; Mohan V; Arunkumar N; Sandhya S; Babu S
    PLoS One; 2015; 10(9):e0137618. PubMed ID: 26367738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.
    Akanmori BD; Kurtzhals JA; Goka BQ; Adabayeri V; Ofori MF; Nkrumah FK; Behr C; Hviid L
    Eur Cytokine Netw; 2000 Mar; 11(1):113-8. PubMed ID: 10705308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.